Tsujiuchi T, Tsutsumi M, Denda A, Amanuma T, Kondoh S, Kamino K, Konishi Y
Department of Oncological Pathology, Nara Medical College, Japan.
Jpn J Cancer Res. 1991 Jul;82(7):793-9. doi: 10.1111/j.1349-7006.1991.tb02704.x.
The effects of an inhibitor of poly(ADP-ribose)polymerase, 3-aminobenzamide (ABA), on N-nitrosobis(2-hydroxypropyl)amine (BHP)-induced pancreas, liver, gallbladder and lung carcinogenesis in Syrian golden hamsters were investigated. Animals were given either BHP alone, by subcutaneous injection at a dose of 500 mg/kg body weight, or in combination with an intraperitoneal injection of ABA 30 min after the BHP at a dose of 300 or 600 mg/kg body weight once a week for 5 weeks, and then killed 35 weeks after the commencement of the experiment. ABA exerted inhibitory effects on pancreas and lung carcinogenesis induced by BHP, with mean numbers of lesions (including hyperplasias and carcinomas) being significantly decreased compared with the BHP-alone group values, while no significant effect was observed on liver or gallbladder carcinogenesis. These results suggest that the effects of ABA on carcinogenesis depend on the target organ as well as the chemical carcinogen examined.
研究了聚(ADP - 核糖)聚合酶抑制剂3 - 氨基苯甲酰胺(ABA)对N - 亚硝基双(2 - 羟丙基)胺(BHP)诱导叙利亚金仓鼠胰腺、肝脏、胆囊和肺癌变的影响。动物分别接受单独皮下注射剂量为500 mg/kg体重的BHP,或在BHP注射30分钟后腹腔注射剂量为300或600 mg/kg体重的ABA,每周一次,共5周,然后在实验开始35周后处死。ABA对BHP诱导的胰腺和肺癌变有抑制作用,与单独使用BHP组相比,病变(包括增生和癌)的平均数量显著减少,而对肝脏或胆囊癌变未观察到显著影响。这些结果表明,ABA对癌变的影响取决于靶器官以及所检测的化学致癌物。